U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Guidance, Compliance, & Regulatory Information
  4. Import Export Compliance Branch (IECB)
  5. CGMP Declarations
  1. Guidance, Compliance, & Regulatory Information

CGMP Declarations

CGMP Declarations

FDA is fulfilling its commitment under the Generic Drug User Fee Amendments of 2017 (GDUFA II) for issuing letters, called current good manufacturing practice (CGMP) declarations, to foreign regulators that convey CGMP compliance status of establishments FDA has inspected.   

As part of this commitment, upon receipt of a request by an establishment physically located in the U.S. that has been included as part of a marketing application submitted to a foreign regulator, FDA will issue within 30 days of receipt of the request, a letter to an identified foreign regulator conveying the current CGMP compliance status for the establishment.

A CGMP declaration should only be requested if a foreign regulator does not accept a valid certificate of pharmaceutical product (CPP) and wants additional assurance of a facility’s CGMP status.

CGMP declarations are one of several ways that FDA is enhancing communication and transparency with foreign regulatory authorities regarding the compliance status of establishments in the United States. Foreign regulators can also find the CGMP status of an establishment by checking the inspection classifications database for the most recent inspection classification.

An establishment may request a CGMP declaration using the agency’s online application process, CDEReCATS (Export Certification and Tracking System), under the following conditions:

  1. An establishment can only request the CGMP status for its own site. Parent and affiliate companies may not request a declaration for an establishment.
  2. An establishment requesting a CGMP declaration must have the latest inspection conducted by the FDA as acceptable.
  3. A requesting establishment must have previously obtained a CPP prior to requesting a CGMP declaration or be able to provide a CPP number in which the establishment is included. This CPP does not need to be for the drug product for which the declaration is being sought but the CPP must be valid and not expired at the time of the declaration request.
  4. A request for a CGMP declaration can only be made using CDEReCATS. To access CDEReCATS, an establishment must have a FURLS account ID and password from the FDA Industry System/FDA Unified Registration and Listing Systems (FURLS). Manufacturers that do not currently have a FURLS account may create a new account.
  5. A CGMP declaration application must include an email address for the foreign regulator. If the CGMP is issued, it will be sent directly to the foreign regulator’s email provided in the application.

Questions?

Contact CDERExportCertificateProgram@fda.hhs.gov.  

Back to Top